Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/30/2872164/0/en/Soleno-Therapeutics-Announces-Peer-Reviewed-Publication-of-Data-Comparing-DCCR-Treatment-to-the-Natural-History-of-Prader-Willi-Syndrome.html
https://www.globenewswire.com/news-release/2024/04/29/2871167/0/en/Soleno-Therapeutics-Receives-Breakthrough-Therapy-Designation-from-U-S-FDA-for-DCCR-Diazoxide-Choline-Extended-Release-Tablets-in-Prader-Willi-Syndrome-PWS.html
https://www.globenewswire.com/news-release/2024/04/19/2866361/0/en/Soleno-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/03/08/2843318/0/en/Soleno-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/03/06/2841776/0/en/Soleno-Therapeutics-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/22/2833627/0/en/Soleno-Therapeutics-to-Present-at-the-TD-Cowen-44th-Annual-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/02/01/2821949/0/en/Soleno-Therapeutics-to-Present-at-Upcoming-February-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/01/29/2819425/0/en/Soleno-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/01/24/2815222/0/en/Soleno-Therapeutics-Strengthens-Leadership-Team-with-Key-Appointments.html
https://www.globenewswire.com//news-release/2024/01/05/2804603/0/en/Soleno-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html